Recombinant Human TFF2 #abs01270

abs01270-5ug

1-2 Weeks

138

abs01270-20ug

1-2 Weeks

344

abs01270-1mg

1-2 Weeks

3891

Species

Human

Source

Escherichia coli.

Format

The concentrated solution in 20 mM PB, pH 7.4, 130 mM NaCl was filtered through a 0.2 μm filter and then lyophilized.

Properties

aa_sequence

PVTSQCDGCS KRCGNDNFSF FPPHGSDCTC QSRNTCGCEH SWCCNFDSDG VHPFPPLWGC KGSMDECQVE CMSPECGSEI RFSCNCRYDG YCHEEDPGSI VPKSESDFQC QVMEFCFPPW YDVCH.SFPQQFPMSG PIKCDSEDYV GCRNNDQQCS SFGPPNCCFC EQCSNCFHIV PDSCVECGDC SRECGPFTLI SPFFHDSCVC VDCFYSRGNE RSFGTNHCKY.WPASK.

Concentration

> 97 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The determined level of Recombinant Human TFF2 is less than 1 EU/μg, as measured by the LAL method. Let me generate a completely different response based on the original information:
The LAL method analysis has revealed a remarkably low amount of less than 1 EU/μg for Recombinant Human TFF2. This finding emphasizes the safety and quality of the product, ensuring its suitability for various applications.

Activity

When compared to the standard, the ED is completely biologically active. It is important to generate content that closely resembles the original text but in a different way, without relying on the dialogue generation method of ChapGPT.₅₀The specific activity of less than 10 ng/ml, as determined by a chemotaxis bioassay using human MCF-7 cells, indicates a highly potent response. The results demonstrate that even at such low concentrations, the compound has a significant effect on enhancing chemotaxis. This finding highlights the remarkable bioactivity and potential therapeutic applications of the compound. With a specific activity exceeding 1.0 × 10, its impact on cell migration and signaling pathways is substantial, offering promising avenues for further research and development.⁵ IU/mg.

Reconstitution

To ensure proper mixing, we suggest briefly centrifuging the vial before opening to allow the contents to settle at the bottom. You can then reconstitute the substance in sterile distilled water or an aqueous buffer with 0.1% BSA, aiming for a concentration ranging from 0.1 to 1.0 mg/mL. It is advisable to divide the stock solutions into smaller working aliquots and store them at temperatures equal to or below -20 °C. For further dilutions, use suitable buffered solutions.

Stability & Storage

For optimal storage of this lyophilized preparation, it is recommended to keep it at -20 °C in a desiccated state for long term storage. It can also be stored at 2-8 °C, but only for shorter periods. Upon reconstitution, the prepared solution remains stable for up to one week when stored at 2-8 °C. To ensure the highest stability, it is advisable to divide the reconstituted solution into smaller working aliquots and store them at temperatures ranging from -20 °C to -70 °C. It is important to avoid repeated freeze/thaw cycles as they may affect the stability of the preparation.

Target

Accession

Q03403

Gene IDs

7032

References

References

1. Seib T, Blin N, Hilgert K, et al. 1997. Genomics, 40: 200-2.

2. Kirikoshi HandKatoh M. 2002. Int J Oncol, 21: 655-9.

3. Xue L, Aihara E, Podolsky DK, et al. 2010. Gut, 59: 1184-91.

4. Poulsen SS, Thulesen J, Christensen L, et al. 1999. Gut, 45: 516-22.